Art

J-GLOBAL ID：202002223034053769   Reference number：20A0751940

Association between High Platelet Reactivity Following Dual Antiplatelet Therapy and Ischemic Events in Japanese Patients with Coronary Artery Disease Undergoing Stent Implantation

ステント留置を受ける冠動脈疾患の日本人患者における二剤抗血小板療法後の高い血小板反応性と虚血イベントの間の関連性

Author (15)： Nishikawa Masakatsu (Clinical Research Support Center, Mie University Hospital) ,  Takeda Yoshihiro (Department of Cardiology, Rinku General Medical Center) ,  Isomura Naoei (Department of Cardiology, Showa University Northern Yokohama Hospital) ,  Tanigawa Takashi (Department of Cardiology, Mie University Faculty of Medicine) ,  Nanasato Mamoru (Cardiovascular Center, Japanese Red Cross Nagoya Daini Hospital) ,  Tsukahara Kengo (Yokohama City University Medical Center) ,  Kimura Kazuo (Yokohama City University Medical Center) ,  Takayama Tadateru (Department of Cardiovascular Medicine, Nihon University Itabashi Hospital) ,  Hirayama Atsushi (Department of Cardiovascular Medicine, Nihon University Itabashi Hospital) ,  Kato Masafumi (Mie Heart Center) ,  Nishikawa Hideo (Mie Heart Center) ,  Nishimura Yuki (Clinical Research Support Center, Mie University Hospital) ,  Isshiki Takaaki (Division of Cardiology, Teikyo University Hospital) ,  Yokoi Hiroyoshi (Cardiovascular Center, Fukuoka Sanno Hospital) ,  Yokoi Hiroyoshi (Division of Cardiology, Kokura Memorial Hospital)
Material： Journal of Atherosclerosis and Thrombosis (Web)  (J Atheroscler Thromb (Web))
Volume： 27  Issue： 1  Page： 13-24(J-STAGE)  Publication year： 2020 
JST Material Number： U0153A  ISSN： 1880-3873  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： therapeutic response

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A0751940&from=J-GLOBAL&jstjournalNo=U0153A") }}

Author keywords (3)： Dual antiplatelet therapy ,  High on-treatment platelet reactivity ,  Coronary stent implantation

JST classification (1)： Treatment for cardiovasular system diseases in general  (GJ05010B)

Substance index (2)： Aspirin ,  Clopidogrel

Reference (29)：

• 1) Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, Granger CB, Lange RA, Mack MJ, Mauri L, Mehran R, Mukherjee D, Newby LK, O’Gara PT, Sabatine MS, Smith PK, Smith SC Jr.: 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery. Circulation, 2016; 134: e123-155
• 2) Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, Jüni P, Kastrati A, Kolh P, Mauri L, Montalescot G, Neumann FJ, Petricevic M, Roffi M, Steg PG, Windecker S, Zamorano JL, Levine GN; ESC Scientific Document Group; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies: 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J, 2018; 39: 213-260
• 3) Mauri L, Kereiakes DJ, Yeh RW, Driscoll-Shempp P, Cutlip DE, Steg PG, Normand SL, Braunwald E, Wiviott SD, Cohen DJ, Holmes Jr DR: Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. NEJM, 2014; 371: 2155-2166
• 4) Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J: Prasugrel versus clopidogrel in patients with acute coronary syndromes. NEJM, 2007; 357: 2001-2015
• 5) Kazui M, Nishiya Y, Ishizuka T, Hagihara K, Farid NA, Okazaki O, Ikeda T, Kurihara A: Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite. Drug Metab Dispos, 2010; 38: 92-99

Terms in the title (9)： ステント留置 ,  冠動脈疾患 ,  日本人 ,  患者 ,  抗血小板療法 ,  血小板反応性 ,  虚血 ,  イベント ,  関連性